Printer Friendly

Articles from Biotech Business (August 1, 2004)

1-4 out of 4 article(s)
Title Author Type Words
BIOSANTE COMPLETES PHASE II TRIAL FOR FSD. 697
DYAX/GENZYME PHASE II TRIAL OF DX-88 MEETS ENDPOINT. 710
EXELIXIS STARTS PHASE 3 TRIAL OF XL119 FOR BILE DUCT CANCER. 716
GLOUCESTER PHASE 2 CLINICAL TRIAL WITH FK228 ENCOURAGING. 768

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters